Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 845 blog entries.

April 2026

AI Trust Issues, Challenges, and Multimodal Insights in Pathology with Hamid R. Tizhoosh, PhD

2026-04-29T08:17:18+00:00

In this must-listen conversation, I sit down with Dr. Hamid Tizhoosh, professor of biomedical informatics at the Mayo Clinic, to confront one of digital pathology’s biggest promises—and its most pressing gaps: AI adoption. Despite the hype, foundation models and large language models are still missing five non-negotiables for clinical relevance: accuracy, consistency, speed, efficiency, and robustness. From [...]

AI Trust Issues, Challenges, and Multimodal Insights in Pathology with Hamid R. Tizhoosh, PhD2026-04-29T08:17:18+00:00

Introducing the New Sylvester Data Portal: Integrating Clinical and Genomic Data into a Unified Platform

2026-04-24T14:58:02+00:00

In a groundbreaking advancement poised to transform cancer research, the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has unveiled its Sylvester Data Portal (SDP)—a state-of-the-art, cloud-based informatics platform that seamlessly integrates extensive clinical and genomic data from diverse sources into a single, unified framework. This revolutionary platform breaks new ground [...]

Introducing the New Sylvester Data Portal: Integrating Clinical and Genomic Data into a Unified Platform2026-04-24T14:58:02+00:00

Fast Organ-of-origin Classification for Digital Pathology Quality Control

2026-04-23T15:31:23+00:00

The following abstract is drawn from a recently published paper in Journal of Pathology Informatics. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Witali Aswolinskiya, John K.L. Wonga, Myroslav [...]

Fast Organ-of-origin Classification for Digital Pathology Quality Control2026-04-23T15:31:23+00:00

Spatial Proteomics Reveals Widespread Immune Dysfunction in Alzheimer’s Disease

2026-04-20T08:42:04+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  A recent spatial imaging study has provided new insights into the role of microglia in Alzheimer’s disease (AD). The study showed that microglial cells exist along a spectrum of activation states rather than in discrete subtypes, and that AD is associated with widespread microglial dysfunction across this spectrum, not just around plaques and tangles. According to the authors, these findings suggest that [...]

Spatial Proteomics Reveals Widespread Immune Dysfunction in Alzheimer’s Disease2026-04-20T08:42:04+00:00

Revolune and MindPeak to Showcase Integrated Multiplex Immunofluorescence Workflow at AACR 2026

2026-04-24T14:52:19+00:00

Partnership highlights streamlined spatial biology workflows combining advanced multiplex IF reagents and AI-powered image analysis Revolune GmbH, a life science company focused on simplifying spatial biology through streamlined multiplex immunofluorescence (mIF) reagents, today announced it will exhibit at the American Association for Cancer Research (AACR) Annual Meeting 2026 together with MindPeak, a leader in AI-powered pathology analysis. At [...]

Revolune and MindPeak to Showcase Integrated Multiplex Immunofluorescence Workflow at AACR 20262026-04-24T14:52:19+00:00

From Slides to Signals: Transforming Biomarker Scoring in Oncology with IHCExplore

2026-04-24T09:38:43+00:00

In the era of ADC-driven precision medicine, a single IHC score can determine whether or not a patient qualifies for a targeted therapy. As treatments grow more sophisticated, the stakes of IHC scoring have never been higher. However, the underlying scoring method has remained unchanged. The current IHC evaluation workflow is semi-quantitative, observer-dependent, and blind to [...]

From Slides to Signals: Transforming Biomarker Scoring in Oncology with IHCExplore2026-04-24T09:38:43+00:00

Waiv Achieves Dual CE Marking Under IVDR, Propelling AI Precision Testing for Breast and Colorectal Cancer for Clinical Routine

2026-04-24T08:28:04+00:00

Waiv, formerly Owkin Dx, a company advancing AI precision testing, today announced that two of its AI precision tests, RlapsRisk® BC for breast cancer prognostic risk profiling and MSIntuit® CRC for colorectal cancer MSI screening, have each received CE marking under the European In Vitro Diagnostic Regulation (IVDR), authorising clinical deployment across EU member states.Improving Patient Outcomes Through AI-Driven [...]

Waiv Achieves Dual CE Marking Under IVDR, Propelling AI Precision Testing for Breast and Colorectal Cancer for Clinical Routine2026-04-24T08:28:04+00:00

England’s National Cancer Plan is More of a Commercial Strategy Than a Health Policy

2026-04-23T09:15:02+00:00

The following abstract is drawn from a recently published paper in the British Medical Journal. We invite you to read the full paper and join the conversation, become a member of the Radiology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Bernard Rachet, professor of cancer epidemiology1,Ajay Aggarwal, [...]

England’s National Cancer Plan is More of a Commercial Strategy Than a Health Policy2026-04-23T09:15:02+00:00

Hospitals Hope AI Can Reduce Burnout, While Workers Push for Staffing Standards

2026-04-21T09:20:36+00:00

AI tools are becoming more commonplace in Pittsburgh hospitals, promising productivity gains for practitioners amid the nursing crisis. But to local hospital employees, enduring understaffing and burnout, another solution is clear: Hire more workers. Pittsburgh’s two hospital giants, Allegheny Health Network (AHN) and the University of Pittsburgh Medical Center (UPMC) are rolling out artificial intelligence tools across [...]

Hospitals Hope AI Can Reduce Burnout, While Workers Push for Staffing Standards2026-04-21T09:20:36+00:00

Mount Sinai Researchers Publish Landmark Cell Review Defining the “Hallmarks of Liver Cancer”

2026-04-21T09:00:52+00:00

Study maps how liver cancer develops and identifies new paths for treatment A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the deadliest cancers worldwide.Published in Cell, the study, “Hallmarks of Liver [...]

Mount Sinai Researchers Publish Landmark Cell Review Defining the “Hallmarks of Liver Cancer”2026-04-21T09:00:52+00:00
Go to Top